Biochemical markers in multiple myeloma: a multivariate analysis
- 1 May 1988
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 69 (1) , 47-53
- https://doi.org/10.1111/j.1365-2141.1988.tb07601.x
Abstract
Summary.The analysis of individual biochemical and clinical variables in 121 patients with multiple myeloma showed that serum β2‐microglobulin (S‐β2m) had the most significant relation to survival. Other variables such as serum thymidine kinase (S‐TK), serum lactate dehydrogenase (S‐LDH), Screatinine, haemoglobin (Hb), ESR, S‐albumin, age and clinical stage were also significant. No such relationship was found with M‐component, presence of light chains in urine, type of secreted immunoglobulin or S‐calcium. The exclusion of clinical stage in the first multivariate analysis resulted in a model consisting of S‐β2m, age and S‐TK, none of the other variables gave additional information. When in the second multivariate analysis the basic variables involved in staging procedure were excluded and clinical stage included, stage III, but not stage II, was found to give additional information to the model described above.Individual analysis of the variables showed that Hb had the most significant relation to effect of initial therapy. Other significant variables were S‐TK, S‐β2m and age. When using the multivariate approach, Hb alone was found to contain all the relevant information.This publication has 26 references indexed in Scilit:
- Prognostic value of serum lactic dehydrogenase (S‐LDH) in multiple myelomaEuropean Journal of Clinical Investigation, 1987
- Pretreatment serum β2‐microglobulin in multiple myelomaBritish Journal of Haematology, 1986
- Beta2 microglobulin in multiple myelomaAmerican Journal of Hematology, 1985
- Evaluation of serum deoxythymidine kinase as a marker in multiple myelomaBritish Journal of Haematology, 1985
- Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myelomaEuropean Journal of Cancer and Clinical Oncology, 1983
- Smoldering Multiple MyelomaNew England Journal of Medicine, 1980
- Intermittent Melphalan and Prednisolone Therapy in Plasma Cell MyelomaActa Medica Scandinavica, 1977
- Prognostic factors in multiple myelomaCancer, 1975
- Recommended Methods for the Determination of Four Enzymes in BloodScandinavian Journal of Clinical and Laboratory Investigation, 1974
- Electroimmuno AssayScandinavian Journal of Clinical and Laboratory Investigation, 1972